Foamix Pharmaceuticals Ltd (FOMX):企業の財務・戦略的SWOT分析

◆英語タイトル:Foamix Pharmaceuticals Ltd (FOMX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14956
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Foamix Pharmaceuticals Ltd (Foamix), formerly Foamix Ltd is a pharmaceutical company that develops and commercializes proprietary topical drugs for various dermatological therapies. The company’s product candidates include FMX101, a minocycline foam which is intended for the treatment of moderate-to-severe acne; FMX 103, for the treatment of rosacea; FMX102, for impetigo; and FDX104, a doxycycline foam for the management of acne-like rash. It also develops various early stage products. The company has partnership with various pharmaceutical companies to develop its product candidates. It has presence in Israel and the US. Foamix is headquartered in Rehovot, Israel.

Foamix Pharmaceuticals Ltd Key Recent Developments

Jan 23,2019: Foamix names Sharon Barbari as Board Director
Jan 23,2019: Foamix names Sharon Barbari as Board Director
Nov 27,2018: Foamix names Wiley to newly-created role of chief commercial officer
Nov 27,2018: Foamix Pharmaceuticals names Matt Wiley as Chief Commercial Officer

This comprehensive SWOT profile of Foamix Pharmaceuticals Ltd provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Foamix Pharmaceuticals Ltd including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Foamix Pharmaceuticals Ltd – Key Information
Foamix Pharmaceuticals Ltd – Overview
Foamix Pharmaceuticals Ltd – Key Employees
Foamix Pharmaceuticals Ltd – Key Employee Biographies
Foamix Pharmaceuticals Ltd – Key Operational Heads
Foamix Pharmaceuticals Ltd – Major Products and Services
Foamix Pharmaceuticals Ltd – History
Foamix Pharmaceuticals Ltd – Company Statement
Foamix Pharmaceuticals Ltd – Locations And Subsidiaries
Foamix Pharmaceuticals Ltd – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Foamix Pharmaceuticals Ltd – Business Description
Foamix Pharmaceuticals Ltd – Corporate Strategy
Foamix Pharmaceuticals Ltd – SWOT Analysis
SWOT Analysis – Overview
Foamix Pharmaceuticals Ltd – Strengths
Foamix Pharmaceuticals Ltd – Weaknesses
Foamix Pharmaceuticals Ltd – Opportunities
Foamix Pharmaceuticals Ltd – Threats
Foamix Pharmaceuticals Ltd – Key Competitors

Section 3 – Company Financial Performance Charts

Foamix Pharmaceuticals Ltd – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Foamix Pharmaceuticals Ltd, Key Information
Foamix Pharmaceuticals Ltd, Key Ratios
Foamix Pharmaceuticals Ltd, Share Data
Foamix Pharmaceuticals Ltd, Major Products and Services
Foamix Pharmaceuticals Ltd, History
Foamix Pharmaceuticals Ltd, Key Employees
Foamix Pharmaceuticals Ltd, Key Employee Biographies
Foamix Pharmaceuticals Ltd, Key Operational Heads
Foamix Pharmaceuticals Ltd, Other Locations
Foamix Pharmaceuticals Ltd, Subsidiaries
Foamix Pharmaceuticals Ltd, Key Manufacturing facilities
Foamix Pharmaceuticals Ltd, Key Competitors
Foamix Pharmaceuticals Ltd, SWOT Analysis
Foamix Pharmaceuticals Ltd, Ratios based on current share price
Foamix Pharmaceuticals Ltd, Annual Ratios
Foamix Pharmaceuticals Ltd, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Foamix Pharmaceuticals Ltd, Performance Chart
Foamix Pharmaceuticals Ltd, Ratio Charts

★海外企業調査レポート[Foamix Pharmaceuticals Ltd (FOMX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Attock Refinery Ltd (ATRL):企業の財務・戦略的SWOT分析
    Summary Attock Refinery Ltd (ARL), a subsidiary of The Attock Oil Co Ltd, is a downstream company that offers refining services. The company refines crude oil and supplies refined petroleum products. Its products include liquefied petroleum gas, petroleum solvent, naphtha, unleaded premium motor gas …
  • Edinburgh Bioquarter:製薬・医療:M&Aディール及び事業提携情報
    Summary Edinburgh Bioquarter (BioQuarter) is an academic medical center that offers translational medicine research services. The center develops new treatments for human and animal diseases by creating new drugs, diagnostic tools and medical devices. It conducts research in the field of regenerativ …
  • Emsland Group:企業の戦略・SWOT・財務分析
    Emsland Group - Strategy, SWOT and Corporate Finance Report Summary Emsland Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • TD Ameritrade Holding Corporation:企業の戦略・SWOT・財務情報
    TD Ameritrade Holding Corporation - Strategy, SWOT and Corporate Finance Report Summary TD Ameritrade Holding Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • KARL STORZ SE & Co KG:企業の戦略的SWOT分析
    KARL STORZ SE & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Kyushu Electric Power Company, Incorporated:企業の戦略・SWOT・財務情報
    Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report Summary Kyushu Electric Power Company, Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • China Oilfield Services Ltd (2883):企業の財務・戦略的SWOT分析
    China Oilfield Services Ltd (2883) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC):企業の財務・戦略的SWOT分析
    Kuwait And Middle East Financial Investment Company (K.S.C.P.) (KMEFIC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view …
  • FTS International Services, LLC-石油・ガス分野:企業M&A・提携分析
    Summary FTS International Services, LLC (FTSI) is a private oilfield services company. It provides a well completion services, including pressure pumping, wireline and reservoir optimization technologies. The company offers products and services to the exploration and production companies to enhance …
  • Alcon Laboratories Inc:企業の戦略的SWOT分析
    Alcon Laboratories Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Nattopharma ASA (NATTO):企業の財務・戦略的SWOT分析
    Summary Nattopharma ASA (Nattopharma) is a pharmaceutical company that develops and sells vitamin K2 for health care industries. The company's MenaQ7, a vitamin K2 as menaquinone-7 for bone and cardiovascular health and children’s health. Its MenaQ7 varieties are suitable for vegans and vegetarians, …
  • East-Central Iowa Rural Electric Cooperative:企業の発電所・SWOT分析2018
    East-Central Iowa Rural Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Caixa Economica Montepio Geral:企業の戦略・SWOT・財務分析
    Caixa Economica Montepio Geral - Strategy, SWOT and Corporate Finance Report Summary Caixa Economica Montepio Geral - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • British American Tobacco p.l.c.:戦略・SWOT・企業財務分析
    British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Delcath Systems Inc (DCTH):医療機器:M&Aディール及び事業提携情報
    Summary Delcath Systems Inc (Delcath) specializes in developing percutaneous perfusion technologies to treat primary and metastatic liver cancers. Its patented drug delivery platform delivers ultra-high doses of anti-cancer drugs to the liver, while preventing them from entering the patient's bloods …
  • Denbury Resources Inc (DNR):企業の財務・戦略的SWOT分析
    Denbury Resources Inc (DNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • AnaptysBio Inc (ANAB):企業の財務・戦略的SWOT分析
    AnaptysBio Inc (ANAB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Yamada Denki Co Ltd:企業の戦略・SWOT・財務情報
    Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Yamada Denki Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Bill Peach Group Limited:企業の戦略・SWOT・財務情報
    Bill Peach Group Limited - Strategy, SWOT and Corporate Finance Report Summary Bill Peach Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Ballard Power Systems Inc. (BLDP)-エネルギー分野:企業M&A・提携分析
    Summary Ballard Power Systems Inc. (Ballard Power) is a renewable energy company. It designs, develops, manufactures, sells, and services proton exchange membrane (PEM) fuel cell products for power product markets, portable power, and material handling and backup power. The company’s product lines i …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆